Northwest Biotherapeutics Inc (QB) (NWBO)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 52.91M | 48.91M | 24.67M | 9.13M | 32.9M | 40.16M | 31.32M | 27.87M |
Total Current Assets | 7.88M | 1.4M | 23.8M | 3.2M | 15.51M | 17.29M | 9.43M | 4.13M |
Cash and Equivalents | 6.19M | 117k | 22.22M | 372k | 9.98M | 15.17M | 6.97M | 2.13M |
Total Non-Current Assets | -26.5M | -67.33M | -47.16M | -43.57M | -362.95M | -123.99M | -128.1M | -65.77M |
Total Liabilities | 79.41M | 96.2M | 71.83M | 52.7M | 395.85M | 164.15M | 136.37M | 74.92M |
Total Current Liabilities | 76.41M | 87.68M | 69.84M | 41.19M | 382.42M | 133.77M | 126.01M | 45.2M |
Total Non-Current Liabilities | 6M | 17.03M | 3.97M | 18.09M | 21.93M | 55.54M | 16.35M | 50.03M |
Total Equity | -26.5M | -67.33M | -47.16M | -43.57M | -362.95M | -123.99M | -128.1M | -65.77M |
Common Equity | 157k | 329k | 523k | 614k | 830k | 948k | 1.07M | 1.18M |
Retained Earnings | -715.48M | -788.62M | -824.41M | -839.91M | -1.37B | -1.19B | -1.3B | -1.36B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.